Every year, more than five million people die due to bacterial infections that are becoming increasingly resistant to a range of antibiotics. It is a concern the World Health Organization has ...

In this context, the use of new antibiotic agents (i.e., linezolid, daptomycin and tigecycline) and the optimization of the pharmacodynamic targets of classic antibiotics (i.e., carbapenems ...